Drugs market is projected to grow from US$ 163040 million in 2024 to US$ 214040 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.

Over The Counter (OTC) Drugs Market

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Market Analysis and Insights: Global Over The Counter (OTC) Drugs Market

The global Over The Counter (OTC)

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Over The Counter (OTC) Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Over The Counter (OTC) Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Over The Counter (OTC) Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Over The Counter (OTC) Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Over The Counter (OTC) Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Over The Counter (OTC) Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Over The Counter (OTC) Drugs Market Report

Report Metric	Details
Report Name	Over The Counter (OTC) Drugs Market
Accounted market size in 2024	US$ 163040 in million
Forecasted market size in 2030	US$ 214040 million
CAGR	4.6
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Analgesics Dermatology Products Gastrointestinal Products Vitamins, Mineral, and Supplements (VMS) Weight Loss/Dietary Products Ophthalmic Products Sleeping Aids Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Over The Counter (OTC) Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Over The Counter (OTC) Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Over The Counter (OTC) Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Over The Counter (OTC) Drugs Market growing?

Ans: The Over The Counter (OTC) Drugs Market witnessing a CAGR of 4.6 during the forecast period 2025-2030.

What is the Over The Counter (OTC) Drugs Market size in 2030?

Ans: The Over The Counter (OTC) Drugs Market size in 2030 will be US$ 214040 million.

Who are the main players in the Over The Counter (OTC) Drugs Market report?

Ans: The main players in the Over The Counter (OTC) Drugs Market are Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan

What are the Application segmentation covered in the Over The Counter (OTC) Drugs Market report?

Ans: The Applications covered in the Over The Counter (OTC) Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others

What are the Type segmentation covered in the Over The Counter (OTC) Drugs Market report?

Ans: The Types covered in the Over The Counter (OTC) Drugs Market report are Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Analgesics

1.2.3 Dermatology Products

1.2.4 Gastrointestinal Products

1.2.5 Vitamins, Mineral, and Supplements (VMS)

1.2.6 Weight Loss/Dietary Products

1.2.7 Ophthalmic Products

1.2.8 Sleeping Aids

1.2.9 Others

1.3 Market by Application

1.3.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacy

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Over The Counter (OTC) Drugs Market Perspective (2019-2030)

2.2 Global Over The Counter (OTC) Drugs Growth Trends by Region

2.2.1 Over The Counter (OTC) Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Over The Counter (OTC) Drugs Historic Market Size by Region (2019-2024)

2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Region (2025-2030)

2.3 Over The Counter (OTC) Drugs Market Dynamics

2.3.1 Over The Counter (OTC) Drugs Industry Trends

2.3.2 Over The Counter (OTC) Drugs Market Drivers

2.3.3 Over The Counter (OTC) Drugs Market Challenges

2.3.4 Over The Counter (OTC) Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Over The Counter (OTC) Drugs by Players

3.1.1 Global Over The Counter (OTC) Drugs Revenue by Players (2019-2024)

3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Over The Counter (OTC) Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio

3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2023

3.5 Global Key Players of Over The Counter (OTC) Drugs Head office and Area Served

3.6 Global Key Players of Over The Counter (OTC) Drugs, Product and Application

3.7 Global Key Players of Over The Counter (OTC) Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Over The Counter (OTC) Drugs Breakdown Data by Type

4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2019-2024)

4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2025-2030)

5 Over The Counter (OTC) Drugs Breakdown Data by Application

5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2019-2024)

5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Over The Counter (OTC) Drugs Market Size (2019-2030)

6.2 North America Over The Counter (OTC) Drugs Market Size by Type

6.2.1 North America Over The Counter (OTC) Drugs Market Size by Type (2019-2024)

6.2.2 North America Over The Counter (OTC) Drugs Market Size by Type (2025-2030)

6.2.3 North America Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

6.3 North America Over The Counter (OTC) Drugs Market Size by Application

6.3.1 North America Over The Counter (OTC) Drugs Market Size by Application (2019-2024)

6.3.2 North America Over The Counter (OTC) Drugs Market Size by Application (2025-2030)

6.3.3 North America Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

6.4 North America Over The Counter (OTC) Drugs Market Size by Country

6.4.1 North America Over The Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Over The Counter (OTC) Drugs Market Size by Country (2019-2024)

6.4.3 North America Over The Counter (OTC) Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Over The Counter (OTC) Drugs Market Size (2019-2030)

7.2 Europe Over The Counter (OTC) Drugs Market Size by Type

7.2.1 Europe Over The Counter (OTC) Drugs Market Size by Type (2019-2024)

7.2.2 Europe Over The Counter (OTC) Drugs Market Size by Type (2025-2030)

7.2.3 Europe Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

7.3 Europe Over The Counter (OTC) Drugs Market Size by Application

7.3.1 Europe Over The Counter (OTC) Drugs Market Size by Application (2019-2024)

7.3.2 Europe Over The Counter (OTC) Drugs Market Size by Application (2025-2030)

7.3.3 Europe Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

7.4 Europe Over The Counter (OTC) Drugs Market Size by Country

7.4.1 Europe Over The Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Over The Counter (OTC) Drugs Market Size by Country (2019-2024)

7.4.3 Europe Over The Counter (OTC) Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Over The Counter (OTC) Drugs Market Size (2019-2030)

8.2 China Over The Counter (OTC) Drugs Market Size by Type

8.2.1 China Over The Counter (OTC) Drugs Market Size by Type (2019-2024)

8.2.2 China Over The Counter (OTC) Drugs Market Size by Type (2025-2030)

8.2.3 China Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

8.3 China Over The Counter (OTC) Drugs Market Size by Application

8.3.1 China Over The Counter (OTC) Drugs Market Size by Application (2019-2024)

8.3.2 China Over The Counter (OTC) Drugs Market Size by Application (2025-2030)

8.3.3 China Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Over The Counter (OTC) Drugs Market Size (2019-2030)

9.2 Asia Over The Counter (OTC) Drugs Market Size by Type

9.2.1 Asia Over The Counter (OTC) Drugs Market Size by Type (2019-2024)

9.2.2 Asia Over The Counter (OTC) Drugs Market Size by Type (2025-2030)

9.2.3 Asia Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

9.3 Asia Over The Counter (OTC) Drugs Market Size by Application

9.3.1 Asia Over The Counter (OTC) Drugs Market Size by Application (2019-2024)

9.3.2 Asia Over The Counter (OTC) Drugs Market Size by Application (2025-2030)

9.3.3 Asia Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

9.4 Asia Over The Counter (OTC) Drugs Market Size by Region

9.4.1 Asia Over The Counter (OTC) Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Over The Counter (OTC) Drugs Market Size by Region (2019-2024)

9.4.3 Asia Over The Counter (OTC) Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Bayer AG

11.1.1 Bayer AG Company Details

11.1.2 Bayer AG Business Overview

11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction

11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.1.5 Bayer AG Recent Developments

11.2 Merck KGaA

11.2.1 Merck KGaA Company Details

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction

11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.2.5 Merck KGaA Recent Developments

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Over The Counter (OTC) Drugs Introduction

11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.3.5 Novartis Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction

11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.4.5 Johnson & Johnson Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction

11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Developments

11.6 Alkem Laboratories

11.6.1 Alkem Laboratories Company Details

11.6.2 Alkem Laboratories Business Overview

11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction

11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.6.5 Alkem Laboratories Recent Developments

11.7 Teva Pharmaceutical Industries

11.7.1 Teva Pharmaceutical Industries Company Details

11.7.2 Teva Pharmaceutical Industries Business Overview

11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction

11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.7.5 Teva Pharmaceutical Industries Recent Developments

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction

11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.8.5 Pfizer Recent Developments

11.9 Sun Pharma

11.9.1 Sun Pharma Company Details

11.9.2 Sun Pharma Business Overview

11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction

11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.9.5 Sun Pharma Recent Developments

11.10 Allergan

11.10.1 Allergan Company Details

11.10.2 Allergan Business Overview

11.10.3 Allergan Over The Counter (OTC) Drugs Introduction

11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.10.5 Allergan Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Teva Pharmaceutical Industries

Sun Pharma

Allergan plc

List of Tables

Table 1. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Analgesics

Table 3. Key Players of Dermatology Products

Table 4. Key Players of Gastrointestinal Products

Table 5. Key Players of Vitamins, Mineral, and Supplements (VMS)

Table 6. Key Players of Weight Loss/Dietary Products

Table 7. Key Players of Ophthalmic Products

Table 8. Key Players of Sleeping Aids

Table 9. Key Players of Others

Table 10. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 11. Global Over The Counter (OTC) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Over The Counter (OTC) Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Over The Counter (OTC) Drugs Market Share by Region (2019-2024)

Table 14. Global Over The Counter (OTC) Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Over The Counter (OTC) Drugs Market Share by Region (2025-2030)

Table 16. Over The Counter (OTC) Drugs Market Trends

Table 17. Over The Counter (OTC) Drugs Market Drivers

Table 18. Over The Counter (OTC) Drugs Market Challenges

Table 19. Over The Counter (OTC) Drugs Market Restraints

Table 20. Global Over The Counter (OTC) Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Over The Counter (OTC) Drugs Revenue Share by Players (2019-2024)

Table 22. Global Top Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2023)

Table 23. Global Over The Counter (OTC) Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 24. Global 5 Largest Players Market Share by Over The Counter (OTC) Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 25. Global Key Players of Over The Counter (OTC) Drugs, Headquarters and Area Served

Table 26. Global Key Players of Over The Counter (OTC) Drugs, Product and Application

Table 27. Global Key Players of Over The Counter (OTC) Drugs, Product and Application

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Over The Counter (OTC) Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2019-2024)

Table 31. Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2025-2030)

Table 33. Global Over The Counter (OTC) Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Over The Counter (OTC) Drugs Revenue Share by Application (2019-2024)

Table 35. Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Over The Counter (OTC) Drugs Revenue Share by Application (2025-2030)

Table 37. North America Over The Counter (OTC) Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 38. North America Over The Counter (OTC) Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 39. North America Over The Counter (OTC) Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 40. North America Over The Counter (OTC) Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 41. North America Over The Counter (OTC) Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. North America Over The Counter (OTC) Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 43. North America Over The Counter (OTC) Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 44. Europe Over The Counter (OTC) Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 45. Europe Over The Counter (OTC) Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 46. Europe Over The Counter (OTC) Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 47. Europe Over The Counter (OTC) Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 48. Europe Over The Counter (OTC) Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Europe Over The Counter (OTC) Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 50. Europe Over The Counter (OTC) Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 51. China Over The Counter (OTC) Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 52. China Over The Counter (OTC) Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 53. China Over The Counter (OTC) Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 54. China Over The Counter (OTC) Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Over The Counter (OTC) Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 56. Asia Over The Counter (OTC) Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 57. Asia Over The Counter (OTC) Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 58. Asia Over The Counter (OTC) Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 59. Asia Over The Counter (OTC) Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 60. Asia Over The Counter (OTC) Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 61. Asia Over The Counter (OTC) Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 67. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 68. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 69. Bayer AG Company Details

Table 70. Bayer AG Business Overview

Table 71. Bayer AG Over The Counter (OTC) Drugs Product

Table 72. Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 73. Bayer AG Recent Developments

Table 74. Merck KGaA Company Details

Table 75. Merck KGaA Business Overview

Table 76. Merck KGaA Over The Counter (OTC) Drugs Product

Table 77. Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 78. Merck KGaA Recent Developments

Table 79. Novartis Company Details

Table 80. Novartis Business Overview

Table 81. Novartis Over The Counter (OTC) Drugs Product

Table 82. Novartis Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 83. Novartis Recent Developments

Table 84. Johnson & Johnson Company Details

Table 85. Johnson & Johnson Business Overview

Table 86. Johnson & Johnson Over The Counter (OTC) Drugs Product

Table 87. Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 88. Johnson & Johnson Recent Developments

Table 89. GlaxoSmithKline Company Details

Table 90. GlaxoSmithKline Business Overview

Table 91. GlaxoSmithKline Over The Counter (OTC) Drugs Product

Table 92. GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 93. GlaxoSmithKline Recent Developments

Table 94. Alkem Laboratories Company Details

Table 95. Alkem Laboratories Business Overview

Table 96. Alkem Laboratories Over The Counter (OTC) Drugs Product

Table 97. Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 98. Alkem Laboratories Recent Developments

Table 99. Teva Pharmaceutical Industries Company Details

Table 100. Teva Pharmaceutical Industries Business Overview

Table 101. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product

Table 102. Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 103. Teva Pharmaceutical Industries Recent Developments

Table 104. Pfizer Company Details

Table 105. Pfizer Business Overview

Table 106. Pfizer Over The Counter (OTC) Drugs Product

Table 107. Pfizer Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 108. Pfizer Recent Developments

Table 109. Sun Pharma Company Details

Table 110. Sun Pharma Business Overview

Table 111. Sun Pharma Over The Counter (OTC) Drugs Product

Table 112. Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 113. Sun Pharma Recent Developments

Table 114. Allergan Company Details

Table 115. Allergan Business Overview

Table 116. Allergan Over The Counter (OTC) Drugs Product

Table 117. Allergan Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 118. Allergan Recent Developments

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Over The Counter (OTC) Drugs Market Share by Type: 2023 VS 2030

Figure 3. Analgesics Features

Figure 4. Dermatology Products Features

Figure 5. Gastrointestinal Products Features

Figure 6. Vitamins, Mineral, and Supplements (VMS) Features

Figure 7. Weight Loss/Dietary Products Features

Figure 8. Ophthalmic Products Features

Figure 9. Sleeping Aids Features

Figure 10. Others Features

Figure 11. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 12. Global Over The Counter (OTC) Drugs Market Share by Application: 2023 VS 2030

Figure 13. Hospital Pharmacies Case Studies

Figure 14. Retail Pharmacies Case Studies

Figure 15. Online Pharmacy Case Studies

Figure 16. Others Case Studies

Figure 17. Over The Counter (OTC) Drugs Report Years Considered

Figure 18. Global Over The Counter (OTC) Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Over The Counter (OTC) Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Over The Counter (OTC) Drugs Market Share by Region: 2023 VS 2030

Figure 21. Global Over The Counter (OTC) Drugs Market Share by Players in 2023

Figure 22. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2023

Figure 24. North America Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

Figure 26. North America Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

Figure 27. North America Over The Counter (OTC) Drugs Market Share by Country (2019-2030)

Figure 28. United States Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Canada Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Europe Over The Counter (OTC) Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 31. Europe Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

Figure 32. Europe Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

Figure 33. Europe Over The Counter (OTC) Drugs Market Share by Country (2019-2030)

Figure 34. Germany Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. France Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. U.K. Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Italy Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Russia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Nordic Countries Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. China Over The Counter (OTC) Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 41. China Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

Figure 42. China Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

Figure 43. Asia Over The Counter (OTC) Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 44. Asia Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

Figure 45. Asia Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

Figure 46. Asia Over The Counter (OTC) Drugs Market Share by Region (2019-2030)

Figure 47. Japan Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. South Korea Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. China Taiwan Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Southeast Asia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. India Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Australia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 54. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Share by Type (2019-2030)

Figure 55. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Share by Application (2019-2030)

Figure 56. Middle East, Africa, and Latin America Over The Counter (OTC) Drugs Market Share by Country (2019-2030)

Figure 57. Brazil Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Mexico Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Turkey Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Saudi Arabia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Israel Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. GCC Countries Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 63. Bayer AG Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 64. Merck KGaA Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 65. Novartis Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 66. Johnson & Johnson Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 67. GlaxoSmithKline Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 68. Alkem Laboratories Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 69. Teva Pharmaceutical Industries Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 70. Pfizer Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 71. Sun Pharma Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 72. Allergan Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions